[artículo] 
inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 138-149

Título :	A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia
Tipo de documento:	texto impreso
Autores:	Yechiel Levkovitz, Autor ; Shlomo Mendlovich, Autor ; Sharon Riwkes, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 138-149
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Cognición, Farmacoterapia, Minociclina, Esquizofrenia, Psicología.
Resumen:	Current antipsychotics have only a limited effect on 2 core aspects of schizophrenia: negative symptoms and cognitive deficits. Minocycline is a second-generation tetracycline that has a beneficial effect in various neurologic disorders. Recent findings in animal models and human case reports suggest its potential for the treatment of schizophrenia.
Link:	./index.php?lvl=notice_display&id=28143

[artículo] A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia [texto impreso] / Yechiel Levkovitz, Autor ; Shlomo Mendlovich, Autor ; Sharon Riwkes, Autor . - 2022 . - pp. 138-149.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 2 (Febrero) . - pp. 138-149

Palabras clave:	Antipsicóticos, Cognición, Farmacoterapia, Minociclina, Esquizofrenia, Psicología.
Resumen:	Current antipsychotics have only a limited effect on 2 core aspects of schizophrenia: negative symptoms and cognitive deficits. Minocycline is a second-generation tetracycline that has a beneficial effect in various neurologic disorders. Recent findings in animal models and human case reports suggest its potential for the treatment of schizophrenia.
Link:	./index.php?lvl=notice_display&id=28143